Fresh Tracks Therapeutics Inc.
Fresh Tracks Therapeutics, Inc. does not have significant operations. Previously, the company was engaged in the development of various prescription therapeutics for the treatment of autoimmune, inflammatory, and other debilitating diseases in the United States. Fresh Tracks Therapeutics, Inc. was founded in 2009 and is headquartered in Boulder, Colorado.
Fresh Tracks Therapeutics Inc. - Asset Resilience Ratio
Fresh Tracks Therapeutics Inc. (FRTX) has an Asset Resilience Ratio of 24.79% as of December 2019. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (1999–2020)
This chart shows how Fresh Tracks Therapeutics Inc.'s Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down Fresh Tracks Therapeutics Inc.'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $4.50 Million | 24.79% |
| Total Liquid Assets | $4.50 Million | 24.79% |
Asset Resilience Insights
- Good Liquidity Position: Fresh Tracks Therapeutics Inc. maintains a healthy 24.79% of assets in liquid form.
- This level provides good financial flexibility while maintaining productive asset deployment.
- The company has significant short-term investments, indicating active treasury management.
Fresh Tracks Therapeutics Inc. Industry Peers by Asset Resilience Ratio
Compare Fresh Tracks Therapeutics Inc.'s asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
MedPacto Inc
KQ:235980 |
Biotechnology | 49.82% |
|
Shenzhen CAU Technology Co Ltd
SHE:000004 |
Biotechnology | 6.20% |
|
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403 |
Biotechnology | 6.88% |
|
Nanhua Bio Medicine Co Ltd
SHE:000504 |
Biotechnology | 11.93% |
|
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518 |
Biotechnology | 0.03% |
|
Chengzhi Shareholding Co Ltd
SHE:000990 |
Biotechnology | 6.73% |
|
Hualan Biological EngineeringInc
SHE:002007 |
Biotechnology | 14.68% |
|
Da An Gene Co Ltd of Sun Yat-Sen University
SHE:002030 |
Biotechnology | 4.35% |
Annual Asset Resilience Ratio for Fresh Tracks Therapeutics Inc. (1999–2020)
The table below shows the annual Asset Resilience Ratio data for Fresh Tracks Therapeutics Inc..
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2020-12-31 | 0.00% | $0.00 | $33.63 Million | -- |
| 2019-12-31 | 24.79% | $4.50 Million | $18.14 Million | -44.37pp |
| 2018-12-31 | 69.16% | $36.20 Million | $52.34 Million | +24.86pp |
| 2017-12-31 | 44.30% | $35.66 Million | $80.49 Million | -14.14pp |
| 2016-12-31 | 58.43% | $30.55 Million | $52.28 Million | +11.84pp |
| 2015-12-31 | 46.60% | $23.26 Million | $49.91 Million | +6.07pp |
| 2014-12-31 | 40.53% | $23.50 Million | $57.98 Million | +23.14pp |
| 2013-12-31 | 17.39% | $11.54 Million | $66.35 Million | -21.60pp |
| 2012-12-31 | 39.00% | $37.64 Million | $96.52 Million | +26.30pp |
| 2011-12-31 | 12.70% | $8.73 Million | $68.77 Million | +5.79pp |
| 2010-12-31 | 6.91% | $5.04 Million | $72.91 Million | -20.38pp |
| 2009-12-31 | 27.29% | $18.39 Million | $67.37 Million | +6.11pp |
| 2008-12-31 | 21.17% | $12.51 Million | $59.06 Million | -18.72pp |
| 2007-12-31 | 39.90% | $36.14 Million | $90.58 Million | -24.80pp |
| 2006-12-31 | 64.70% | $81.03 Million | $125.25 Million | +0.40pp |
| 2005-12-31 | 64.29% | $60.78 Million | $94.53 Million | +11.32pp |
| 2004-12-31 | 52.98% | $53.63 Million | $101.23 Million | -6.27pp |
| 2003-12-31 | 59.24% | $65.59 Million | $110.71 Million | -1.72pp |
| 2002-12-31 | 60.96% | $78.90 Million | $129.43 Million | +2.48pp |
| 2001-12-31 | 58.48% | $90.35 Million | $154.49 Million | -22.34pp |
| 2000-12-31 | 80.82% | $131.66 Million | $162.90 Million | +22.06pp |
| 1999-12-31 | 58.76% | $26.50 Million | $45.10 Million | -- |